Abstract:Particle maturation is a critical step in the HIV-1 replication cycle that requires proteolytic cleavage of the Gag polyprotein into its constitutive proteins: the matrix (MA), capsid (CA), nucleocapsid (NC), and p6 proteins. The accurate and efficient cleavage of Gag is essential for virion infectivity; inhibitors of the viral protease are potent antivirals, and substitutions in Gag that prevent its cleavage result in reduced HIV-1 infectivity. In a previous study, a mutation inhibiting cleavage at the MA-CA junction was observed to potently inhibit virus infection: incorporation of small amounts of uncleaved MA-CA protein into HIV-1 particles inhibited infectivity by ∼95%, and the resulting viral particles exhibited aberrant capsids. Here we report a detailed mechanistic analysis of HIV-1 particles bearing uncleaved MA-CA protein. We show that the particles contain stable cores and can efficiently saturate host restriction by TRIMCyp in target cells. We further show that MA-CA associates with CA in particles without detectably affecting the formation of intermolecular CA interfaces. Incorporation of MA-CA did not markedly affect reverse transcription in infected cells, but nuclear entry was impaired and integration targeting was altered. Additionally, results from mutational analysis of Gag revealed that membrane-binding elements of MA contribute to the antiviral activity of uncleaved MA-CA protein. Our results suggest that small amounts of partially processed Gag subunits coassemble with CA during virion maturation, resulting in impaired capsid functions.IMPORTANCE To become infectious, newly formed HIV-1 particles undergo a process of maturation in which the viral polyproteins are cleaved into smaller components. A previous study demonstrated that inclusion of even small quantities of an uncleavable mutant Gag polyprotein results in a strong reduction in virus infectivity. Here we show that the mechanism of transdominant inhibition by uncleavable Gag involves inhibition of nuclear entry and alteration of viral integration sites. Additionally, the results of mutational analysis suggest that the membrane-binding activity of Gag is a major requirement for the antiviral activity. These results further define the antiviral mechanism of uncleavable Gag, which may be useful for exploiting this effect to develop new antivirals.

Mutations in the matrix protein of human immunodeficiency virus type 1 inhibit surface expression and virion incorporation of viral envelope glycoproteins in CD4+ T lymphocytes.

A mutation in the human immunodeficiency virus type 1 Gag protein destabilizes the interaction of the envelope protein subunits gp120 and gp41.

Mutations in the Cytoplasmic Domain of Human Immunodeficiency Virus Type 1 Transmembrane Protein Impair the Incorporation of Env Proteins into Mature Virions.

The C Terminus of Human Immunodeficiency Virus Type 1 Matrix Protein is Involved in Early Steps of the Virus Life Cycle

Mutations In The N-Terminal Region Of Human-Immunodeficiency-Virus Type-1 Matrix Protein Block Intracellular-Transport Of The Gag Precursor

Structural maturation of the matrix lattice is not required for HIV-1 particle infectivity

Second site reversion of HIV-1 envelope protein baseplate mutations maps to the matrix protein

A Bipartite Membrane-Binding Signal in the Human Immunodeficiency Virus Type 1 Matrix Protein is Required for the Proteolytic Processing of Gag Precursors in A Cell Type-Dependent Manner

Single Amino-Acid Changes In Hiv Envelope Affect Viral Tropism And Receptor-Binding

Dominant Negative MA-CA Fusion Protein is Incorporated into HIV-1 Cores and Inhibits Nuclear Entry of Viral Preintegration Complexes.

Mutations that mimic phosphorylation of the HIV-1 matrix protein do not perturb the myristyl switch.

Human Immunodeficiency Virus Type 2 Capsid Protein Mutagenesis Reveals Amino Acid Residues Important for Virus Particle Assembly

Mutations of the Human Immunodeficiency Virus Type 1 P6gag Domain Result in Reduced Retention of Pol Proteins During Virus Assembly.

Proline Residues in Human Immunodeficiency Virus Type 1 P6 Gag Exert a Cell Type-Dependent Effect on Viral Replication and Virion Incorporation of Pol Proteins

Amino Acid Changes in the Fourth Conserved Region of Human Immunodeficiency Virus Type 2 Strain HIV-2ROD Envelope Glycoprotein Modulate Fusion

The conserved HIV-1 spacer peptide 2 triggers matrix lattice maturation

HIV-1 Matrix-Trna Complex Structure Reveals Basis for Host Control of Gag Localization.

Critical Amino Acids Within the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein V4 N- and C-terminals Contribute to Virus Entry.

Maturation-Dependent Human Immunodeficiency Virus Type 1 Particle Fusion Requires a Carboxyl-Terminal Region of the Gp41 Cytoplasmic Tail

Variations in Env at amino acids 328 and 330 affect HIV-1 replicative fitness and entry inhibitor sensitivity

Loss of CD4 Membrane Expression and CD4 Mrna During Acute Human Immunodeficiency Virus Replication.